Los Angeles Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

Los Angeles Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,553	Closed	-$613K	–	1514
2022 Q1	$613K	Sell	20,553 -8,070	-28%	-$236K	﹤0.01%	952
2021 Q4	$667K	Sell	28,623 -167	-0.6%	-$4.44K	﹤0.01%	881
2021 Q3	$898K	Sell	28,790 -335	-1%	-$10.4K	﹤0.01%	802
2021 Q2	$1.02M	Buy	29,125 +1,090	+4%	+$35.4K	﹤0.01%	847
2021 Q1	$988K	Sell	28,035 -11,130	-28%	-$411K	﹤0.01%	897
2020 Q4	$1.47M	Buy	39,165 +18,275	+87%	+$665K	0.01%	771
2020 Q3	$697K	Buy	20,890 +7,780	+59%	+$227K	﹤0.01%	951
2020 Q2	$347K	Buy	+13,110	New	+$309K	﹤0.01%	1242

Other funds holding ALBO

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Los Angeles Capital Management's ALBO Position: Q2 2022 in Review

Los Angeles Capital Management sold out of Albireo Pharma Inc (ALBO) in Q2 2022, closing a stake of 20,553 shares — an estimated $613K sold.

Los Angeles Capital Management first reported a position in ALBO in Q2 2020 and held it in 8 quarters. The position peaked at $1.47M in Q4 2020. 103 funds tracked by Wall St. Rank hold ALBO as of Q2 2022.

Los Angeles Capital Management reported no remaining Albireo Pharma Inc position as of Q2 2022 after selling out during the quarter.
Los Angeles Capital Management sold 20,553 Albireo Pharma Inc shares in Q2 2022, an estimated $613K.
Los Angeles Capital Management first reported a position in Albireo Pharma Inc in Q2 2020 and held it in 8 quarters.
Los Angeles Capital Management's Albireo Pharma Inc position peaked at $1.47M in Q4 2020.
103 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2022.

Based on Los Angeles Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.